Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
by on Wednesday, July 11th, 2012 | No Comments
Condition: Recurrent Small Cell Lung Cancer
Interventions: Drug: veliparib; Drug: temozolomide; Other: placebo; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); National Cancer Institute (NCI)
Not yet recruiting – verified July 2012
See the article here: Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer